Miklós Garami
- Genetics top 2%
- Glioma Diagnosis and Treatment 28
- Neurology top 5%
- Neuroblastoma Research and Treatments 22
- Cancer Research top 10%
-
- Vitamin D Research Studies 5
- Molecular Biology top 10%
-
- Childhood Cancer Survivors' Quality of Life 17
-
- Sarcoma Diagnosis and Treatment 10
-
- Acute Lymphoblastic Leukemia research 6
-
- Neuroendocrine Tumor Research Advances 5
-
- Neutropenia and Cancer Infections 5
- Co-authors
- David G. GardnerJiangping WuTong ChengPéter HauserLászló BognárNada JabadoDamien FauryJianming Wu
- Cited by
- GeneticsNeurologyCancer Research
- Journals
- Journal of Clinical Oncology (6 papers)Journal of Pediatric Hematology/Oncology (4 papers)Pathology & Oncology Research (4 papers)
- Partner nations
- HungaryUnited StatesGermany
In The Last Decade
Miklós Garami
106 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 112
- Genetics 523
- Neurology 392
- Cancer Research 228
- Pathology and Forensic Medicine 246
- Molecular Biology 809
Countries citing papers authored by Miklós Garami
This map shows the geographic impact of Miklós Garami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miklós Garami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miklós Garami more than expected).
Fields of papers citing papers by Miklós Garami
This network shows the impact of papers produced by Miklós Garami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miklós Garami. The network helps show where Miklós Garami may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miklós Garami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 7 | |
| 12 | 2022 | 8 | |
| 13 | 2017 | 14 | |
| 14 | 2016 | 4 | |
| 15 | 2012 | 3 | |
| 16 | Early high-dose treatment: SCT results from the European High Risk Neuroblastoma Study | 2011 | 1 |
| 17 | 2007 | 7 | |
| 18 | PCR based diagnosis of 21-hydroxylase gene defects in Slovak patients with congenital adrenal hyperplasia. | 2000 | 3 |
| 19 | [Survival of Ewing' s sarcoma patients in Hungary] | 2000 | 1 |
| 20 | 1997 | 74 |
About Miklós Garami
Miklós Garami is a scholar working on Genetics, Neurology and Pediatrics, Perinatology and Child Health, having authored 117 papers that have together received 2.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (28 papers), Neuroblastoma Research and Treatments (22 papers), Childhood Cancer Survivors' Quality of Life (17 papers), Sarcoma Diagnosis and Treatment (10 papers), Acute Lymphoblastic Leukemia research (6 papers), Vitamin D Research Studies (5 papers), Neuroendocrine Tumor Research Advances (5 papers) and Neutropenia and Cancer Infections (5 papers). The work is most often cited by research in Genetics (523 citations), Neurology (392 citations) and Cancer Research (228 citations). Miklós Garami has collaborated with scholars based in Hungary, United States and Germany. Frequent co-authors include David G. Gardner, Jiangping Wu, Tong Cheng, Péter Hauser, László Bognár, Nada Jabado, Damien Faury, Jianming Wu, Faquan Liang and Katalin Dankó. Their work appears in journals such as Journal of Clinical Oncology, Journal of Pediatric Hematology/Oncology, Pathology & Oncology Research, Journal of the American College of Nutrition and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.